Bastiaens Guido J H, Baarslag Tom, Pelgrum Corinne, Mascini Ellen M
1Laboratory for Medical Microbiology and Medical Immunology, Rijnstate Hospital, Pres. Kennedylaan 100, 6883 AZ Velp, The Netherlands.
2Department of Medical Microbiology & Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Antimicrob Resist Infect Control. 2020 Jan 7;9(1):8. doi: 10.1186/s13756-019-0670-8. eCollection 2020.
We evaluated a new hospital policy comprising active surveillance for highly resistant microorganisms (HRMO) in patients with prolonged hospitalization, including detection of nosocomial transmission after identification of HRMO carriers. Our findings raise the question of whether active surveillance should be extended from traditional risk groups to patients with prolonged hospitalization.
我们评估了一项新的医院政策,该政策包括对长期住院患者的高度耐药微生物(HRMO)进行主动监测,其中包括在确定HRMO携带者后检测医院内传播情况。我们的研究结果提出了一个问题,即主动监测是否应从传统风险群体扩展到长期住院患者。